Chemical Compound

Etamycin

CAS Registry Number 102646-56-0
Etamycin chemical structure
Primary Record

Etamycin

In stock
5,043 g
Purity
98.3 %
CAS
102646-56-0

Compound Identifiers & Properties

CAS
102646-56-0
PubChem CID
417256
SMILES
CC1C(C(=O)NC(C(=O)N2CC(CC2C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)O1)C3=CC=CC=C3)C)C)C(C)C(C)C)C)C)O)CC(C)C)NC(=O)C4=C(C=CC=N4)O
Canonical SMILES
CC(C)CC1NC(=O)C(NC(=O)c2ncccc2O)C(C)OC(=O)C(c2ccccc2)N(C)C(=O)C(C)NC(=O)C(C(C)C(C)C)N(C)C(=O)CN(C)C(=O)C2CC(O)CN2C1=O

Names & Synonyms

  • Etamycin
  • Viridogrisein
  • Viridogrisein I
  • Etamycin A
  • Fijimycin A
  • Neoviridogrisein IV
  • Antibiotic 6613
  • ENTAMYCIN
  • Antibiotic K-179
  • Antibioticum 6613
  • Antibiotic F-1370A
  • RefChem:1067982
  • UNII-PAF72P8T3G
  • Antibioticum 6613 [German]
  • AC1L9D7A
  • NSC88468
  • SATIISJKSAELDC-UHFFFAOYSA-N
  • SCHEMBL4088801
  • CHEMBL1993563
  • SCHEMBL29403733
  • AEC46721
  • C44H62N8O11
  • CID417256
  • NSC-88468
  • BS-1380
  • C44-H62-N8-O11
  • BRN 0078383
  • J981.041B
  • 4-27-00-09723 (Beilstein Handbook Reference)
  • 102646-56-0
  • 299-20-7
  • 3-hydroxy-N-[24-hydroxy-7,11,13,17,20-pentamethyl-16-(3-methylbutan-2-yl)-3-(2-methylpropyl)-2,5,9,12,15,18,21-heptaoxo-10-phenyl-8-oxa-1,4,11,14,17,20-hexazabicyclo[20.3.0]pentacosan-6-yl]pyridine-2-carboxamide
  • Viridogrisein I; Etamycin A; Neoviridogrisein IV; K-179; F-1370-A; 6613; NSC-88468
  • 1350467-21-8
  • 3-Hydroxy-N-(24-Hydroxy-7,11,13,17,20-Pentamethyl-16-(3-Methylbutan-2-Yl)-3-(2-Methylpropyl)-2,5,9,12,15,18,21-Heptaoxo-10-Phenyl-8-Oxa-1,4,11,14,17,20-Hexazabicyclo(20.3.0)Pentacosan-6-Yl)Pyridine-2-Carboxamide
  • 3-hydroxy-N-[23-hydroxy-2,5,9,11,15-pentamethyl-6-(3-methylbutan-2-yl)-19-(2-methylpropyl)-1,4,7,10,13,17,20-heptaoxo-12-phenyl-docosahydro-1H-pyrrolo[2,1-o]1-oxa-4,7,10,13,16,19-hexaazacyclodocosan-16-yl]pyridine-2-carboxamide
  • 3-Phenyl-4,6,10,13,22-pentamethyl-9-(1,2-dimethylpropyl)-18-(2-methylpropyl)-21-[[(3-hydroxy-2-pyridyl)carbonyl]amino]-24-hydroxy-15,16-propano-1-oxa-4,7,10,13,16,19-hexaazacyclodocosane-2,5,8,11,14,17,20-heptone
  • Glycine, N-[(3-hydroxy-2-pyridinyl)carbonyl]-L-threonyl-D-leucyl-4-allo-hydroxy-D-prolyl-N-methylglycyl-N,3,4-trimethyl-L-norvalyl-L-alanyl-N-methyl-L-2-phenyl-, .upsilon.-lactone
  • Glycine, N-[N-[N-[N-[4-allo-hydroxy-1-[N-[N-[(3-hydroxy-2-pyridinyl)carbonyl]-L-threonyl]-D-leucyl]-D-prolyl]-N-methylglycyl]-N,3-dimethyl-L-leucyl]-L-alanyl]-N-methyl-L-2-phenyl-, .upsilon.-lactone
  • N-(6-(1,2-Dimethylpropyl)-23-hydroxy-19-isobutyl-2,5,9,11,15-pentamethyl-1,4,7,10,13,17,20-heptaoxo-12-phenyldocosahydro-1H-pyrrolo[2,1-o][1,4,7,10,13,16,19]oxahexaazacyclodocosin-16-yl)-3-hydroxy-2-pyridinecarboxamide
  • N-[16-(1,2-dimethylpropyl)-24-hydroxy-3-isobutyl-7,11,13,17,20-pentamethyl-2,5,9,12,15,18,21-heptaoxo-10-phenyl-8-oxa-1,4,11,14,17,20-hexazabicyclo[20.3.0]pentacosan-6-yl]-3-hydroxy-pyridine-2-carboxamide
  • N-[N-[N-[N-[4-Allo-hydroxy-1-[N-[N-[(3-hydroxy-2-pyridinyl)carbonyl]-L-threonyl]-D-leucyl]-D-prolyl]-N-methylglycyl]-N,3-dimethyl-L-leucyl]-L-alanyl]-N-methyl-L-2-phenylglycine .upsilon.-lactone